Literature DB >> 23991664

Reply: Adverse effects of long-acting beta-agonists on airway hyperresponsiveness.

Gloria S Forkuo, Vaidehi J Thanawala, Nour Al-Sawalha, Richard A Bond, Julia K L Walker.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23991664      PMCID： PMC3824060          DOI： 10.1165/rcmb.2013-0161LE

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN： 1044-1549            Impact factor:   6.914


× No keyword cloud information.
  4 in total

Review 1.  Partial agonists and G protein-coupled receptor desensitization.

Authors:  R B Clark; B J Knoll; R Barber
Journal:  Trends Pharmacol Sci       Date:  1999-07       Impact factor: 14.819

Review 2.  New perspectives regarding β(2) -adrenoceptor ligands in the treatment of asthma.

Authors:  J K L Walker; R B Penn; N A Hanania; B F Dickey; R A Bond
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

3.  The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol.

Authors:  Daniel K C Lee; Graeme P Currie; Ian P Hall; John J Lima; Brian J Lipworth
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

4.  beta-arrestin-biased agonism at the beta2-adrenergic receptor.

Authors:  Matthew T Drake; Jonathan D Violin; Erin J Whalen; James W Wisler; Sudha K Shenoy; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2007-12-17       Impact factor: 5.157
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.